术前患者报告结局指标作为全髋关节置换术指征的适当性
该回顾性研究分析18006例连续初次全髋关节置换术患者,以术前HOOS-JR评分40、50、60、70分为理论阈值,发现若以高于阈值拒绝手术,被拒患者中1年MCID达标率仍达75.9%至42.1%,而获准手术者MCID达标率更高但非家庭出院和90天再入院率也更高。结论认为设置术前PROM阈值并不能保证临床成功结局。
要点
- 术前HOOS-JR阈值40、50、60、70分时,被拒手术患者比例分别为70.4%、43.2%、20.3%、8.3%。
- 被拒手术患者1年MCID达标率分别为75.9%、69.0%、59.1%、42.1%。
- 获准手术患者MCID达标率更高(P < .001),但非家庭出院(P = .01)和90天再入院率(P = .036)也更高。
核心结论
- 多数患者在全部理论PROM阈值下均达到MCID,且并发症和再入院率低。
- 设置术前PROM阈值作为全髋关节置换术资格条件并不能保证临床成功结局。
研究设计与样本
- 回顾性分析2016年至2019年18006例连续初次全髋关节置换术患者。
- 以术前HOOS-JR评分40、50、60、70分为理论阈值,低于阈值视为「获准」手术,高于阈值视为「被拒」手术。
- 评估院内并发症、90天再入院和出院去向,术前及术后1年收集HOOS-JR评分,采用既往验证的锚定法计算MCID达标情况。
主要发现
- 术前HOOS-JR阈值40、50、60、70分时,被拒手术患者比例分别为70.4%、43.2%、20.3%、8.3%。
- 被拒手术患者1年MCID达标率分别为75.9%、69.0%、59.1%、42.1%。
- 获准手术患者院内并发症率分别为3.3%、3.0%、2.8%、2.7%,90天再入院率分别为5.1%、4.4%、4.2%、4.1%。
- 获准手术患者MCID达标率高于被拒患者(P < .001),但非家庭出院率(P = .01)和90天再入院率(P = .036)也高于被拒患者。
关键数值与推荐
- 术前HOOS-JR阈值40分时,被拒手术比例70.4%,被拒患者1年MCID达标率75.9%。
- 术前HOOS-JR阈值50分时,被拒手术比例43.2%,被拒患者1年MCID达标率69.0%。
- 术前HOOS-JR阈值60分时,被拒手术比例20.3%,被拒患者1年MCID达标率59.1%。
- 术前HOOS-JR阈值70分时,被拒手术比例8.3%,被拒患者1年MCID达标率42.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While Medicare requires patient-reported outcome measures (PROMs) for many quality programs, some commercial insurers have begun requiring preoperative PROMs when determining patient eligibility for total hip arthroplasty (THA). Concerns exist these data may be used to deny THA to patients above a specific PROM score, but the optimal threshold is unknown. We aimed to evaluate outcomes following THA based on theoretical PROM thresholds. METHODS: We retrospectively analyzed 18,006 consecutive primary THA patients from 2016-2019. Hypothesized preoperative Hip Disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS-JR) cutoffs of 40, 50, 60, and 70 points were used. Preoperative scores below each threshold were considered "approved" surgery. Preoperative scores above each threshold were considered "denied" surgery. In-hospital complications, 90-day readmissions, and discharge disposition were evaluated. HOOS-JR scores were collected preoperatively and 1-year postoperatively. Minimum clinically important difference (MCID) achievement was calculated using previously validated anchor-based methods. RESULTS: Using preoperative HOOS-JR thresholds of 40, 50, 60, and 70 points, the percentage of patients who would have been denied surgery was 70.4%, 43.2%, 20.3%, and 8.3%, respectively. For these denied patients, 1-year MCID achievement was 75.9%, 69.0%, 59.1%, and 42.1%, respectively. In-hospital complication rates for approved patients were 3.3%, 3.0%, 2.8%, and 2.7%, while 90-day readmission rates were 5.1%, 4.4%, 4.2%, and 4.1%, respectively. Approved patients had higher MCID achievement (P < .001) but higher nonhome discharge (P = .01) and 90-day readmissions rates (P = .036) than denied patients. CONCLUSION: Most patients achieved MCID at all theoretical PROM thresholds with low complication and readmission rates. Setting preoperative PROM thresholds for THA eligibility did not guarantee clinically successful outcomes.
引用
- Sutton RM, Baker CM, D'Amore T, et al. The Appropriateness of Preoperative Patient Reported Outcome Measures as an Indication for Total Hip Arthroplasty. J Arthroplasty. 2022. PMID: 37343279. doi:10.1016/j.arth.2022.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。